Samuel Gonzalez is a results-driven biopharmaceutical executive and patient advocacy leader specializing in community engagement, strategic marketing, and global patient-centered care. Since earning his EMPH, Samuel has built a distinguished career across industry leaders including Gilead Sciences, Global Blood Therapeutics, and Pfizer. Currently serving as the National Patient Engagement Director in ATTR-CM at Pfizer, he builds and leads high-performing patient navigation teams, establishes patient support frameworks, and drives global patient engagement roadmaps. His extensive leadership experience spans launching high-impact community awareness initiatives in sickle cell disease and cardiovascular health, directing foundation partnerships, and elevating the patient voice within clinical product development.

“I was hesitant to go back for a second master’s degree, specifically because I was already tracking toward the goals that I had planned. However, being part of the EMPH Program opened my eyes to so many other possibilities. I made so many new friends and colleagues that I know I can count on to guide me in my career, and that is the most invaluable part of the EMPH Program.”